Relationship between sipuleucel-T (sip-T) cytolytic T lymphocyte (CTL) activity and overall survival (OS) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Charles G. Drake,Emmanuel S. Antonarakis,Daniel Peter Petrylak,David I. Quinn,Adam S. Kibel,Nancy N. Chang,Erica Dearstyne,Dwayne Campogan,Heather Haynes,Tuyen Vu,Nadeem A. Sheikh,Eric J. Small

Relationship between sipuleucel-T (sip-T) cytolytic T lymphocyte (CTL) activity and overall survival (OS) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

2018

Charles G. Drake
Emmanuel S. Antonarakis
Daniel Peter Petrylak
David I. Quinn
Adam S. Kibel
Nancy N. Chang
Erica Dearstyne
Dwayne Campogan
Heather Haynes
Tuyen Vu
Nadeem A. Sheikh
Eric J. Small

5027Background: Sip-T, an autologous cellular immunotherapy approved in the US for pts with asymptomatic/minimally symptomatic mCRPC, is produced by culturing peripheral blood mononuclear cells wit...

Keywords:

Lymphocyte
Sipuleucel-T
Prostate cancer
CTL*
Pathology
Cancer research
Medicine
Peripheral blood mononuclear cell
Asymptomatic
in patient
t lymphocyte
Cytolysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations